Stay updated on Regorafenib Pembrolizumab CRC Clinical Trial
Sign up to get notified when there's something new on the Regorafenib Pembrolizumab CRC Clinical Trial page.

Latest updates to the Regorafenib Pembrolizumab CRC Clinical Trial page
- ChecktodayChange DetectedRevision: v3.6.5 was added, replacing Revision: v3.6.4. This indicates a small update to the study record on ClinicalTrials.gov without altering the study information.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe revision tag updated from v3.6.3 to v3.6.4, indicating a new build or update to the page's backend/content.SummaryDifference0.1%

- Check22 days agoNo Change Detected
- Check36 days agoChange DetectedThe page's revision version was updated from v3.6.2 to v3.6.3, indicating a small maintenance update to the documentation.SummaryDifference0.1%

- Check43 days agoChange DetectedRevision tag updated from v3.6.0 to v3.6.2, indicating a small site update. No study information or user-facing content appears to be altered.SummaryDifference0.1%

- Check50 days agoChange DetectedResults posting details were added to the record, indicating that results were posted on 2026-06-16 with associated outcome descriptions and a linked Study Protocol and Statistical Analysis Plan PDF. The reported number of patients with dose modification due to toxicity was updated to 73 (from 75).SummaryDifference2%

- Check57 days agoChange DetectedThe page now signals that recruitment is closed and provides enhanced guidance sections to help readers understand the study details and joining process.SummaryDifference0.5%

Stay in the know with updates to Regorafenib Pembrolizumab CRC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Regorafenib Pembrolizumab CRC Clinical Trial page.